Please login to the form below
MEDI1814
This page shows the latest MEDI1814 news and features for those working in and with pharma, biotech and healthcare.
Biogen rises on more positive data for Alzheimer's candidate
compounds. . Last week, it partnered with AstraZeneca (AZ) on MEDI1814, an antibody against amyloid-beta 42 (Aβ42) in phase I trials, and is also working with AZ on BACE inhibitor AZD3293,
Latest news
-
Lilly taps AstraZeneca for another anti-amyloid drug
Lilly and AZ will collaborate on the development of MEDI1814, an antibody against amyloid-beta 42 (Aβ42), which is currently in phase I trials. ... MEDI1814 dose-dependently reduces levels of the Aβ42 peptide - which is thought to be particularly
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
- Client Services Director- Flexible Working
-
Negotiable
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Events Executive
-
DOE
-
Account Director – UK Office
-
Excellent salary and benefits
-
Senior Medical Writer
-
Competitive salary plus benefits
- Account Manager – Healthcare advertising
-
Salary TBC
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- Envision Pharma Group relocates to support expansion
- Biogen loses another pipeline drug to toxicity concerns
- AZ, Merck’s Lynparza scores market-expanding clinical success
- AbbVie/Allergan's merger faces public opposition
- How can we realise the benefits of patient engagement?
- Half of European cancer drug trials ‘biased’, says BMJ
- Four Health and ARK among winners at PM Society Digital Awards
- Democrats’ final pricing plan announced, 250 drugs targeted
- Insys gets bankruptcy court okay for Subsys sale
- Breath test could predict response to immunotherapy
PMHub
Hanson Zandi
Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...
Latest intelligence
- Report: Customer experience, shaping digital healthcare
- In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
- Encouraging signs in biomarker R&D
- The cancer immunotherapy firms ramping-up biomarker R&D...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Quick links
Infographics
